197 related articles for article (PubMed ID: 25597908)
1. AC5 Surgical Hemostat™ as an effective hemostatic agent in an anticoagulated rat liver punch biopsy model.
Csukas D; Urbanics R; Moritz A; Ellis-Behnke R
Nanomedicine; 2015 Nov; 11(8):2025-31. PubMed ID: 25597908
[TBL] [Abstract][Full Text] [Related]
2. Effects of Algan Hemostatic Agent on bleeding time in a rat tail hemorrhage model.
Gedar Totuk ÖM; Güzel ŞE; Ekici H; Kumandaş A; Emre Aydıngöz S; Yılmaz EÇ; Kırdan T; Midi A
Ulus Travma Acil Cerrahi Derg; 2020 Nov; 26(6):853-858. PubMed ID: 33107963
[TBL] [Abstract][Full Text] [Related]
3. The effect of chitosan (poly-N-acetyl glucosamine) on lingual hemostasis in heparinized rabbits.
Klokkevold PR; Fukayama H; Sung EC; Bertolami CN
J Oral Maxillofac Surg; 1999 Jan; 57(1):49-52. PubMed ID: 9915395
[TBL] [Abstract][Full Text] [Related]
4. Self-Assembling Peptide Solution Accelerates Hemostasis.
Carter T; Qi G; Wang W; Nguyen A; Cheng N; Ju YM; Lee SJ; Yoo JJ; Atala A; Sun XS
Adv Wound Care (New Rochelle); 2021 Apr; 10(4):191-203. PubMed ID: 32716728
[No Abstract] [Full Text] [Related]
5. Hemostatic efficacy of EVARREST™, Fibrin Sealant Patch vs. TachoSil® in a heparinized swine spleen incision model.
Matonick JP; Hammond J
J Invest Surg; 2014 Dec; 27(6):360-5. PubMed ID: 25361019
[TBL] [Abstract][Full Text] [Related]
6. An In Vivo Comparison of Hemostatic Gelatin Matrix Products in a Porcine Spleen Biopsy-punch Model.
Hutchinson RW; Werrlein S; Johns DB; Zhang G; Clymer JW; Kocharian R
Surg Technol Int; 2015 Nov; 27():53-7. PubMed ID: 26680379
[TBL] [Abstract][Full Text] [Related]
7. Use of topical bovine thrombin in an anti-coagulated rat model of hepatic injury.
Schmiedt CW; Köhler R; Brainard BM
Res Vet Sci; 2012 Dec; 93(3):1498-503. PubMed ID: 22633173
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of a hemostatic agent in anticoagulant drug-induced rat bleeding model.
Sönmez E; Cavuş UY; Civelek C; Dur A; Karayel E; Gülen B; Uysal O; Ipek G
Ulus Travma Acil Cerrahi Derg; 2014 Mar; 20(2):79-85. PubMed ID: 24740331
[TBL] [Abstract][Full Text] [Related]
9. Hemostatic efficacy of biological self-assembling peptide nanofibers in a rat kidney model.
Song H; Zhang L; Zhao X
Macromol Biosci; 2010 Jan; 10(1):33-9. PubMed ID: 19705375
[TBL] [Abstract][Full Text] [Related]
10. Laboratory Assessment of Hemostatic and Anticoagulant Therapy.
Adcock DM; Gosselin RC
Semin Thromb Hemost; 2017 Apr; 43(3):242-244. PubMed ID: 28346961
[No Abstract] [Full Text] [Related]
11. Slounase, a Batroxobin Containing Activated Factor X Effectively Enhances Hemostatic Clot Formation and Reducing Bleeding in Hypocoagulant Conditions in Mice.
Adili R; Jackson M; Stanger L; Dai X; Li M; Li BX; Holinstat M
Clin Appl Thromb Hemost; 2021; 27():10760296211018510. PubMed ID: 34047195
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of a novel polyoxazoline-based hemostatic patch in liver and spleen surgery.
Roozen EA; Lomme RMLM; Calon NUB; Ten Broek RPG; van Goor H
World J Emerg Surg; 2023 Mar; 18(1):19. PubMed ID: 36918896
[TBL] [Abstract][Full Text] [Related]
13. Hemostatic properties of a venomic protein in rat organ trauma.
Warner RL; McClintock SD; Barron AG; de la Iglesia FA
Exp Mol Pathol; 2009 Dec; 87(3):204-11. PubMed ID: 19747909
[TBL] [Abstract][Full Text] [Related]
14. Assessment of topical hemostats in a renal hemorrhage model in heparinized rats.
Tuthill DD; Bayer V; Gallagher AM; Drohan WN; MacPhee MJ
J Surg Res; 2001 Feb; 95(2):126-32. PubMed ID: 11162035
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a novel hemostatic device in an ovine parenchymal organ bleeding model of normal and impaired hemostasis.
Turner AS; Parker D; Egbert B; Maroney M; Armstrong R; Powers N
J Biomed Mater Res; 2002; 63(1):37-47. PubMed ID: 11787027
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of aprotinin with various anticoagulant agents in cardiopulmonary bypass.
Terrell MR; Walenga JM; Koza MJ; Pifarré R
Ann Thorac Surg; 1996 Aug; 62(2):506-11. PubMed ID: 8694614
[TBL] [Abstract][Full Text] [Related]
17. Heparin-level-based anticoagulation management during cardiopulmonary bypass: a pilot investigation on the effects of a half-dose aprotinin protocol on postoperative blood loss and hemostatic activation and inflammatory response.
Koster A; Huebler S; Merkle F; Hentschel T; Gründel M; Krabatsch T; Tambeur L; Praus M; Habazettl H; Kuebler WM; Kuppe H
Anesth Analg; 2004 Feb; 98(2):285-290. PubMed ID: 14742356
[TBL] [Abstract][Full Text] [Related]
18. Use of fibrin sealant to reduce bleeding after needle liver biopsy in an anticoagulated canine model: work in progress.
Falstrom JK; Moore MM; Caldwell SH; Matsumoto AH; Abbott RD; Spotnitz WD
J Vasc Interv Radiol; 1999 Apr; 10(4):457-62. PubMed ID: 10229475
[TBL] [Abstract][Full Text] [Related]
19. Hemostatic agents for bleeding: recombinant-activated factor VII and beyond.
Franchini M; Crestani S; Frattini F; Sissa C; Bonfanti C
Semin Thromb Hemost; 2015 Apr; 41(3):342-7. PubMed ID: 24937097
[TBL] [Abstract][Full Text] [Related]
20. [Local hemostatic agent - fluid active hemostatic matrix].
Zemlyanoy AB
Khirurgiia (Mosk); 2019; (5):104-115. PubMed ID: 31169828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
